Results 101 to 110 of about 2,551 (122)
A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.
, 2007 Type 2 diabetes (T2D) is a progressive disorder with a consistent and steady increase in glycosylated hemoglobin (HbA1c) over time associated with enhanced risk of micro- and macrovascular complications and a substantial reduction in life expectancy ...
Mozhgan Dorkhan +3 more
core
Vascular Health and Risk Management, 2012 Glimepiride: evidence-based facts, trends, and observationsBasit A, Riaz M, Fawwad A Vascular Health and Risk Management 2012, 8:463–472The title of the paper should have read "Glimepiride: evidence-based facts, trends, and ...
Basit A, Riaz M, Fawwad A
doaj
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Glimepiride: Role of a New Sulfonylurea in the Treatment of Type 2 Diabetes Mellitus
Annals of Pharmacotherapy, 1998R K Campbell
exaly
Sulfonylurea Treatment of Type 2 Diabetes Mellitus: Focus on Glimepiride
Pharmacotherapy, 2004Mary Korytkowski
exaly
Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride
British Journal of Clinical Pharmacology, 2000Janne Tapio Backman +2 more
exaly
HPLC study of glimepiride under hydrolytic stress conditions
Journal of Pharmaceutical and Biomedical Analysis, 2004Jiří Klimeš, Petra Kovařı́Ková
exaly
Effect of glimepiride on the skeletal system of ovariectomized and non-ovariectomized rats
Pharmacological Reports, 2014Maria Pytlik
exaly
Cholestatic liver injury after glimepiride therapy
Journal of Hepatology, 2005Sotirios Tsiodras, Helen Giamarellou
exaly